MicroRNAs belong to a family of small (~23 nt) non-coding RNAs that mediate posttranscriptional gene silencing. They are emerging as important new regulators of differentiation and development. Knowledge of their role in pancreas and islet development, may help in developing a regenerative therapy for diabetes mellitus, a metabolic disorder affecting hundreds of millions of people worldwide. In this minireview, we summarize the latest evidence of the role these new regulators play in islet lineage development, aiming to attract more research into this important developmental regulators.
Introduction
Various families of transcription factors (TFs) are known to be essential regulators of differentiation and development [1] . In addition, microRnAs (miRs), a family of non-coding small RnAs, have recently emerged as important regulatory molecules [2, 3] . miRs are small (~23 nt) RnAs [4] that can mediate posttranscriptional gene silencing by binding perfectly or imperfectly to the 3' untranslated region of their cognate mRnA sequences and forming an RnAinduced silencing complex (RISc) [4] .
Studies in recent years have begun to shed light on the importance of miR species on the development of islet cells. The latter play a key role in maintaining glucose homeostasis, dysregulation of which may result in diabetes mellitus, a metabolic disorder currently affecting approximately 346 million people worldwide [5] . To better understand the roles of miRs on pancreas and islet lineage development, a brief introduction of normal development of the pancreas will be provided. In this minireview, we will briefly introduce the biogenesis of miR species, summarize the current knowledge of these species on islet lineage development that may stimulate further research in this area. Readers interested in effects of miRs on other traits relevant to diabetes, such as b-cell function, glucose homeostasis, and pancreas regeneration are referred to recent reviews [6] [7] [8] [9] [10] .
Development of islet cells
The islets of Langerhans are embedded within the pancreas, an endoderm-derived organ. The endoderm is one of the three primitive germ layers formed during the early embryonic stage known as gastrulation. Taking the mouse as an example, the pancreas originates from the thickened definite endoderm epithelium along the dorsal and ventral surfaces of the posterior foregut. These thickenings can be identified histologically at embryonic day (E) 9.0-9.5 [11] , and are marked by the expression of Pdx1 (pancreas and duodenum transcription factor 1), a TF essential for pancreas outgrowth in early development and b-cell function in adults [12, 13] . Shortly afterwards, a small group of cells emerges, marked by expression of neurogenin 3 (ngn3), a basic helix-loop-helix transcription factor [12, 14, 15] .
These are islet progenitors and can give rise to all mature cell types of the islet. Subsequently, these epithelia evaginate into the surrounding mesoderm-derived mesenchymal tissue and form dorsal and ventral pancreatic buds. These buds continue to expand, branch and fuse as a result of gut rotation bringing the buds together. The fused developing pancreas continues to proliferate, differentiate and, ultimately, develop into the mature pancreas. concomitant with pancreas organogenesis, ngn3 + progenitors differentiate into five types of islet cells that work collectively to control glucose homeostasis. The biological process and its regulation by key transcription factors are simplified in Figure 1 and also discussed in more detail in recent reviews [16] [17] [18] .
Biogenesis of miR species
There are at least two biochemical pathways for synthesis of miRs. most are formed from the canonical pathway, which Direct evidence that miRs modulate pancreas and islet development
As it encodes the Rnase III enzyme required for generation of mature miR, Dicer1 is critical for global production of major, if not all, miR species. Hence, genetic deletion of this gene should provide an ideal model to understand the function of this new regulatory species in pancreatic endocrine development. Indeed, when Dicer1 is deleted in Pdx1-expressing cells, the resulting animals exhibit gross, dramatic defects in all three pancreatic lineages including exocrine, ductal and endocrine tissues. In particular, the number of glucagon-secreting a, insulin-secreting b, somatostatin-secreting g and pancreatic polypeptidesecreting PP cells was reduced at E18.5 by 79%, 94%, 95% and 86% respectively [22] (Figure 2 ). These data convincingly indicate that miR species as a whole play key roles in islet cell development. This is a remarkable achievement and sets the stage for identifying which particular miR or cluster of miRs is critical for involves four steps. First, in the nucleus, the RnA polymerase II synthesises a 5′-capped, spliced, and polyadenylated primary RnA precursor (pri-miR), consisting of a stem (containing the miR) and a terminal loop. Second, the enzyme Drosha in the nuclear microprocessor complex catalyzes the removal of the flanking sequences from the pri-miR and releases an intermediate stem-loop structure (known as premiR, ∼70 nt). Third, the pre-miR is then transported to the cytoplasm by exportin-5. Fourth, the cytoplasmic Rnase III Dicer1 mediates the generation of a mature miR duplex which is finally incorporated into the RISc to recognize and bind the target mRnA and perform its biological function. In the non-canonical pathway, miRs are transcribed directly as endogenous short hairpin RnAs or produced directly through splicing from introns that refold into hairpins; the last two steps are the same as in the canonical pathway. Readers are referred to recent excellent reviews for detailed description of miR biogenesis [19] [20] [21] and roles in general differentiation and cell fate decisions [3] . to a progressive decrease of b-cell number and mass [28] .
Further studies showed that deletion of Dicer1 in b cells halved production of miR-7 and miR-375, and dramatically reduced insulin mRnA and protein [28, 29] miR-375 modulates islet cell fate
In addition to regulating insulin secretion [30] , miR-375 plays multiple roles in the development of pancreatic endocrine cells.
It is highly expressed during specification of definitive endoderm [31] though its function at this stage remains to be identified. As miR-375 colocalizes with Pdx1 in the E14.5 pancreas [22] , it may play a role in affecting lineage specifications during pancreas and islet development. Indeed, mice lacking miR-375 exhibit an increased number of a cells with a decreased number of b cells, and develop postnatal hyperglycemia [32] . However, targeted inhibition of miR-375 by morphino (a synthetic oligonucleotide which specifically targets mature miR or its precursor and temporally knocks down the miR) in zebrafish only disturbs the architecture, but not the cellular development of the islets [33] .
Whether this discrepancy is due to a species difference needs to be addressed. miR-7 modulates islet cell fate miR-7 is an evolutionarily conserved miR species encoded by three different genomic loci in humans and mice (for example in mice: mmu-mir-7a-1, mmu-mir-7a-2 and mmu-mir-7b).
Immunostaining showed that miR-7 colocalizes with islet progenitors [34] . Knockdown of miR-7 by intrauterine fetal heart injection of antisense morphino decreased b-cell number and insulin production and, induced postnatal glucose intolerance and -195 are associated with ngn3 expression; overexpression of these miRs in the developing pancreas in vitro inhibits the differentiation of both a and b cells [24] . How these miR species regulate differentiation of ngn3 + progenitors remain to be delineated.
In humans, miR profiling also reveals that miRs-7, -9, -375 are highly expressed during pancreatic islet development [25] .
Real time quantitative RT-PcR analysis showed that miR-7
is expressed in the developing human pancreas from around 9 week gestational age (wga) and peaks between 14 and 18 wga, a period in which the number of endocrine cells increase exponentially [26] . consistent with this, in situ hybridization analysis confirms that miR-7 is mainly expressed in developing islet cells that express Pdx1, ngn3 and Isl1 [27] .
Deletion of dicer1 provides direct evidence that miRs modulate islet function
As Dicer1 is up-regulated (2.6-fold) again from E18. Hnf6 promoter activity [36] . In contrast, repressing Ptf1a activity in the multipotent AR42J cell line leads to overexpression of miR-18a and reduces levels of amylase 2 and carboxypeptidase 1 mRnAs (markers of acinar cells) [37] . However, whether this suggests that miR-18a has a role in specification of pancreatic progenitors requires further investigation ( Figure 3) . Finally, the Let7 family is the first discovered, highly conserved miR species. mice with Pdx1-controled overexpression of Let7 do not exhibit glucose-induced intolerance unlike with systematic overexpression which reduces GSIS [38, 39] , suggesting that this family may not modulate islet development and function. A high level expression of miR-30 family is essential for maintenance of the epithelial phenotype of hormone-secreting cells [40] .
Furthermore, miR-30d is capable of inducing insulin gene expression [41] via a mafA-associated mechanism [42] .
concluding remarks This is partially due to the absence of suitable systems for islet cell development and simple readout assays. As TFs are key regulators for cell fate and lineage differentiation, it is reasonable to believe that miRs act by degrading or inhibiting cognate transcription factor mRnAs. We believe that genetic loss and gain functional studies (including tissue-specific and temporal manipulations) on miR species need to be strengthened. now 
